@article{30a7d6f452844a98ba01a524be16c1e9,
title = "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia",
author = "Barth, \{Brian M.\} and Weiyuan Wang and Toran, \{Paul T.\} and Fox, \{Todd E.\} and Charyguly Annageldiyev and Ondrasik, \{Regina M.\} and Keasey, \{Nicole R.\} and Brown, \{Timothy J.\} and Devine, \{Viola G.\} and Sullivan, \{Emily C.\} and Cote, \{Andrea L.\} and Vasiliki Papakotsi and Tan, \{Su Fern\} and Shanmugavelandy, \{Sriram S.\} and Deering, \{Tye G.\} and Needle, \{David B.\} and Stern, \{Stephan T.\} and Junjia Zhu and Jason Liao and Viny, \{Aaron D.\} and Feith, \{David J.\} and Levine, \{Ross L.\} and Wang, \{Hong Gang\} and Loughran, \{Thomas P.\} and Arati Sharma and Mark Kester and Claxton, \{David F.\}",
note = "Funding Information: This work was funded in part by grants from the National Institutes of Health, National Cancer Institute (P01 CA171983 [M.K., T.P.L., and H.-G.W.] and K22 CA190674 [B.M.B.]), a Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA0087480) (R.L.L.), a National Institute of General Medical Sciences, University of New Hampshire COBRE Pilot Project Grant (P20 GM113131) (B.M.B.), the Bess Family Charitable Fund (T.P.L.), a generous anonymous donor (T.P.L.), the Penn State University Kiesendahl Family Endowed Leukemia Research Fund and the Kenneth Noel Memorial Fund (D.F.C.), and Pennsylvania Tobacco Settlement funds (M.K. and T.P.L.).",
year = "2019",
month = sep,
day = "10",
doi = "10.1182/bloodadvances.2018021295",
language = "English (US)",
volume = "3",
pages = "2598--2603",
journal = "Blood Advances",
issn = "2473-9529",
publisher = "Elsevier Inc.",
number = "17",
}